Profilo
Mattis F.
Ranthe served as the Chief Medical Officer at Expres2ion Biotech Holding AB from 2022 to 2023.
Prior to this, he obtained a doctorate degree from the University of Copenhagen in 2013.
Precedenti posizioni note di Mattis Ranthe
| Società | Posizione | Fine |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Direttore Tecnico/Scientifico/R&S | 31/12/2023 |
Formazione di Mattis Ranthe
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
















